Case studies

Phase 2 study in neurodegenerative disease

How Adnexi powered a patient lead generation program to accelerate Phase 2 enrollment in neurodegenerative disease.

Results

Patients completed pre-screen
250
Patients completed screening at an active site
52
Patients randomized in 9 months
24

Situation

A biopharmaceutical company enrolling a phase 2 clinical trial in a very serious neurodegenerative disease wanted help to accelerate clinical trial enrollment.

Approach

  • Designed and implemented a compliant patient lead generation program targeting recently diagnosed patients
  • Directed patients to a clinical trial website with a digital prescreener
  • Activated the Adnexi Portal for 50 sites across the United States and Canada